The Effect Of Simvastatin On Bone Remodeling In Socket Of Mandibular Teeth
NCT01085149 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2010-03-11
Summary
Simvastatin has been reported to promote osteoblastic activity and inhibit osteoclastic activity by enhancing the expression of BMP2. There have been many studies demonstrating the bone-promoting effect of local application various animal models including after application into socket of teeth in a rat. the purpose of the study is to investigate the effect of slow release topical simvastatin in socket of mandibular teeth on bone remodeling in the socket
Conditions
Interventions
- DRUG
-
Simvastatin
10 mg simvastatin, slow release in socket of extracted tooth (single application only)
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
casap nardi, MD, DMD · Hadassah Medical Organization
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2010-10-31
Countries
- Israel
Study Locations
More Related Trials
-
Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
NCT00051636 ·Status: COMPLETED ·Phase: PHASE3
-
Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
NCT00131118 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Long-term Use of Bisphosphonates on Femur Morphology
NCT06621069 ·Status: COMPLETED
-
Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
NCT00431444 ·Status: COMPLETED ·Phase: PHASE4
-
Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial
NCT03576599 ·Status: TERMINATED ·Phase: PHASE4
-
Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women
NCT00372099 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD
NCT00577837 ·Status: COMPLETED ·Phase: PHASE2
-
Bisphosphonate Therapy for Osteogenesis Imperfecta
NCT00159419 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA
NCT02333344 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis
NCT01675297 ·Status: COMPLETED ·Phase: PHASE4
-
Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid
NCT00097812 ·Status: COMPLETED ·Phase: PHASE3
-
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
NCT01194440 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid
NCT04719650 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Denosumab Therapy for Japanese
NCT02491515 ·Status: UNKNOWN
-
Effect of Riociguat on Bone Metabolism
NCT00855660 ·Status: COMPLETED ·Phase: PHASE1
-
Osteoclast Inhibition and Bone Formation
NCT02554695 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women
NCT00927186 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Pitavastatin on Bone
NCT06359353 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis
NCT05305183 ·Status: UNKNOWN ·Phase: PHASE3
-
3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs
NCT00718861 ·Status: COMPLETED ·Phase: PHASE3
-
Bone Effects of Teriparatide Following Alendronate
NCT00191893 ·Status: COMPLETED ·Phase: PHASE3
-
Dental Care and Initiation of Anti-osteoporotic Therapy
NCT05719818 ·Status: COMPLETED
-
TST002 Intervenous Injection in Postmenopausal Women and Men With Reduced Bone Mineral Density
NCT05391776 ·Status: UNKNOWN ·Phase: PHASE1
-
Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass
NCT00489424 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
NCT00103740 ·Status: COMPLETED ·Phase: PHASE3